Biotron Limited
BITRF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $2 | $2 | $1 | $2 |
| % Growth | 10.2% | 14.9% | -8.2% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $2 | $2 | $1 | $2 |
| % Margin | 100% | 97.5% | 97% | 97.1% |
| R&D Expenses | $1 | $4 | $3 | $3 |
| G&A Expenses | $1 | $1 | $2 | $1 |
| SG&A Expenses | $2 | $1 | $2 | $1 |
| Sales & Mktg Exp. | $1 | $1 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $2 | $5 | $5 | $4 |
| Operating Income | -$0 | -$4 | -$4 | -$3 |
| % Margin | -18.7% | -213.1% | -252.1% | -178.1% |
| Other Income/Exp. Net | $0 | $0 | $0 | -$0 |
| Pre-Tax Income | -$0 | -$3 | -$3 | -$3 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$0 | -$3 | -$3 | -$3 |
| % Margin | -17.6% | -208.9% | -244% | -178.4% |
| EPS | -0 | -0.004 | -0.004 | -0.004 |
| % Growth | 92.1% | 11.6% | -13.2% | – |
| EPS Diluted | -0 | -0.004 | -0.004 | -0.004 |
| Weighted Avg Shares Out | 1,002 | 902 | 821 | 725 |
| Weighted Avg Shares Out Dil | 999 | 902 | 821 | 725 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$0 | -$4 | -$4 | -$3 |
| % Margin | -18.4% | -213% | -251.6% | -175.2% |